{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:19:03Z","timestamp":1791202743087,"version":"4.2.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jaci.2012.06.011","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T07:35:11Z","timestamp":1343720111000},"page":"486-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation"],"prefix":"10.1016","volume":"131","author":[{"given":"Aude","family":"Magerus-Chatinet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Stolzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Lanzarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Daussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Neveux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.06.011_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-3476(67)80262-2","article-title":"Chronic lymphoadenopathy simulating malignant lymphoma","volume":"70","author":"Canale","year":"1967","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.06.011_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2012.06.011_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2012.06.011_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib5","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib6","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood.V97.10.3161","article-title":"Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression","volume":"97","author":"Lopatin","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/clim.2001.5069","article-title":"TcR-alpha\/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis","volume":"100","author":"Bleesing","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2012.06.011_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","article-title":"Fas and Fas ligand: lpr and gld mutations","volume":"16","author":"Nagata","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2012.06.011_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.immuni.2008.07.016","article-title":"Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis","volume":"29","author":"Hao","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2012.06.011_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2012.06.011_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2141.2006.05993.x","article-title":"Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype","volume":"133","author":"Worth","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2012.06.011_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V89.4.1341","article-title":"Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis","volume":"89","author":"Sneller","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.cdd.4401190","article-title":"Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways","volume":"10","author":"Rieux-Laucat","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaci.2012.06.011_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/10.2.195","article-title":"Novel Fas (CD95\/APO-1) mutations in infants with a lymphoproliferative disorder","volume":"10","author":"Kasahara","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2012.06.011_bib15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2012.06.011_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.06.011_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2012.06.011_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2350-8-41","article-title":"Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib","volume":"8","author":"Bi","year":"2007","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jaci.2012.06.011_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2012.06.011_bib20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","article-title":"A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib21","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2007-05-088286","article-title":"Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes","volume":"110","author":"Mateo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.06.011_bib22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","article-title":"Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome","volume":"125","author":"Caminha","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912009645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912009645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:41:54Z","timestamp":1758789714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912009645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0091674912009645"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.06.011","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}